Apollo Hospitals Enterprise Limited appears to be a financially healthy company with strengths in profitability and growth. The company's ROE and EBITDA margins are respectable, indicating efficient use of shareholder capital. Revenue and earnings growth rates are also promising, suggesting a strong future outlook. However, the company's valuation is relatively high, with a trailing P/E of 68.81 and forward P/E of 85.08, which may indicate that the stock is overpriced. A notable weakness is the high debt-to-equity ratio of 90.89, which may pose a risk to the company's financial stability if not managed properly.